ENHANCED PERMEATION OF THEOPHYLLINE THROUGH THE SKIN AND ITS EFFECT ON FIBROBLAST PROLIFERATION

被引:15
作者
TOUITOU, E
LEVISCHAFFER, F
SHACOEZRA, N
BENYOSSEF, R
FABIN, B
机构
[1] School of Pharmacy, Hebrew University of Jerusalem, Jerusalem
关键词
THEOPHYLLINE; ENHANCED PERMEATION; FIBROBLAST; PSORIASIS; OLEIC ACID; TRANSCUTOL;
D O I
10.1016/0378-5173(91)90176-O
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is believed that theophylline can be helpful in psoriasis treatment by elevating cAMP levels. In the present study, theophylline skin permeation behavior from various enhancing carriers, as well as its efficacy in inhibiting psoriatic fibroblast proliferation in vitro, was studied. The results show that theophylline markedly inhibited normal and psoriatic dermal fibroblast proliferation when added to the cells at 1 mM concentration. Lower theophylline concentrations had no effect on psoriatic fibroblasts. From these results it can be assumed that a high concentration of drug needs to reach the dermis in order to be effective. The effect of oleic acid, propylene glycol and transcutol on the skin permeation fluxes of theophylline from various carrier systems (PEG base, cream, gel and ointment) was measured. The results clearly indicate that PEG base containing oleic acid and transcutol is the best enhancing carrier for theophylline (yielding a 260-times flux increase), among the systems investigated. This enhancing formulation was found to deliver to the dermis radiolabeled theophylline when applied to rat skin in vivo and visualized by autoradiography.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 21 条
[1]  
BARRY BW, 1989, PERCUTANEOUS ABSORPT, P531
[2]   EFFECT OF FATTY-ACIDS AND ALCOHOLS ON THE PENETRATION OF ACYCLOVIR ACROSS HUMAN-SKIN INVITRO [J].
COOPER, ER ;
MERRITT, EW ;
SMITH, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (06) :688-689
[3]  
Evain-Brion D., 1986, P NATL ACAD SCI USA, V83, P5272, DOI [10.1073/pnas.83.14.5272, DOI 10.1073/PNAS.83.14.5272]
[4]  
GILMAN AG, 1985, PHARMACOL BASIS THER, P589
[5]  
GOLDMAN R, 1979, J NATL CANCER I, V63, P1009
[6]  
HORI M, 1989, PERCUTANEOUS ABSORPT, P197
[7]   TRIALS WITH XANTHINE DERIVATIVES IN SYSTEMIC TREATMENT OF PSORIASIS [J].
IANCU, L ;
SHNEUR, A ;
COHEN, H .
DERMATOLOGICA, 1979, 159 (01) :55-61
[8]  
IANCU L, 1979, THESIS TELAVIV U
[9]  
MENCZEL E, 1989, PERCUTANEOUS ABSORPT, P121
[10]   PRO-DRUGS AS DRUG DELIVERY SYSTEMS .23. IMPROVED DERMAL DELIVERY OF 5-FLUOROURACIL THROUGH HUMAN-SKIN VIA N-ACYLOXYMETHYL PRO-DRUG DERIVATIVES [J].
MOLLGAARD, B ;
HOELGAARD, A ;
BUNDGAARD, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 12 (2-3) :153-162